NCT03803163View on ClinicalTrials.gov

A Safety, Tolerability and Pharmacokinetics Study of TransCon Treprostinil in Healthy Adult Male Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

TransCon Treprostinil

Sponsors
All Listed Sponsors
lead

Ascendis Pharma A/S

INDUSTRY